Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions

Diabetes Obes Metab

Hakariya H, Ohnishi M, Tanimoto T

2024/5/15

https://pubmed.ncbi.nlm.nih.gov/38747140/